ECM Remodeling in Excessive Fibroplasia
ECM Remodeling in Excessive Fibroplasia
批准号:
7935388
负责人:
Paul David Benya
金额:
$39.48万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2012-08-31
关键词:
AffectAfricanAntibodiesAsiansBindingCellsCicatrixCollagenEpitope MappingEpitopesExhibitsExtracellular MatrixFibrinFibroblastsFundingGelGoalsHispanicsHumanIntegrinsKeloidLaboratory FindingMediatingMolecularMonitorMonoclonal AntibodiesMutant Strains MicePathway interactionsPatientsPeptide HydrolasesPeptidesPhosphotransferasesPlasminogen Activator Inhibitor 1ProductionRNA InterferenceRegulationRegulatory PathwayResearchRoleSignal TransductionSignal Transduction PathwaySkinSmall Interfering RNATestingTherapeuticTransfectionViralVitronectinWound Healingbaseclinically relevantknock-downmonolayermutantoverexpressionpolyclonal antibodypopulation basedpreventreceptor expressionrepositoryresponsetumor
中文摘要
这项研究的长期目标是阐明糖尿病的细胞和分子基础。
在伤口修复过程中形成过多的疤痕。瘢痕疙瘩是一种肿瘤样皮肤疤痕,影响
10%到20%的非洲体面人、亚洲人和西班牙人没有适当的
治疗。在过去的资助期间,我们使用了14个新隔离的低通道
(<;3)株正常人和瘢痕疙瘩成纤维细胞,并提供了新的
有证据表明(PAI-1)过表达和胶原沉积增加是固有的
瘢痕疙瘩成纤维细胞的特征。我们还提供了新的和不同的因果关系证据。
纤溶酶原激活物-1表达与胶原堆积的关系:腺病毒
过度表达和siRNA和shRNAmir抑制表明PAI-1产生
正常成纤维细胞和瘢痕疙瘩成纤维细胞中的胶原堆积分别增加。最后,通过
检测PAI-1的蛋白水解酶抑制突变体和玻璃体连接蛋白结合突变体的能力
诱导胶原蛋白堆积,我们发现后者与野生型相当
PAI-1,前者的有效率仅为50%。因此,PAI-1利用蛋白酶抑制作为
以及它的另一个控制胶原堆积的功能(Tuan等人,2008,Am J
帕索尔)。续签申请的目标是1)推进一种治疗策略,
以纤溶酶原激活物抑制物-1为靶点控制瘢痕疙瘩胶原堆积
并预防或治疗瘢痕疙瘩的形成;2)进一步明确和拓展其作用机制
被PAI-1用来调节瘢痕疙瘩成纤维细胞中胶原的积累。
英文摘要
The long term goal of the research is to elucidate the cellular and molecular basis of
excess scar formation during wound repair. Keloids are tumor-like skin scars that affect
10 to 20% of people of African decent, Asians, and Hispanics without appropriate
treatments. During the past funding period, we used 14 freshly isolated and low passages
(<3) strains of normal and keloid fibroblasts from human patients and provided new
evidence that (PAI-1) overexpression and elevated collagen accumulation are intrinsic
features of keloid fibroblasts. We also provided new and different evidence of a causal
relationship between PAI-1 expression and collagen accumulation: adenoviral
overexpression and siRNA and shRNAmir suppression demonstrate that PAI-1 produces
elevated collagen accumulation in normal and keloid fibroblasts, respectively. Finally, by
testing protease-inhibitory and vitronectin-binding mutants of PAI-1 for their capacity to
induce collagen accumulation, we found that the latter was equipotent with wild-type
PAI-1 and the former was only ~50% effective. Thus, PAI-1 utilizes protease inhibition as
well as another of its functions to control collagen accumulation (Tuan et al., 2008, Am J
Pathol). The goals of the renewal application are 1) to advance a therapeutic strategy that
targets plasminogen activator inhibitor-1 (PAI-1) to control keloid collagen accumulation
and prevent or treat keloid formation; 2) to further define and expand the mechanisms
utilized by PAI-1 to regulate collagen accumulation in keloid fibroblasts.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/nprot.2011.440
发表时间:
2012-01-19
期刊:
Nature protocols
影响因子:
14.8
作者:
[]
通讯作者:
DOI:
10.1111/j.1524-475x.2012.00814.x
发表时间:
2012-09
期刊:
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society
影响因子:
--
作者:
[Lien CL, Harrison MR, Tuan TL, Starnes VA]
通讯作者:
Starnes VA
DOI:
10.1002/bdrc.21017
发表时间:
2012-09
期刊:
BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
影响因子:
--
作者:
[Lee, Yun-Shain, Wysocki, Annette, Warburton, David, Tuan, Tai-Lan]
通讯作者:
Tuan, Tai-Lan
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models
-
批准号:8452052
-
项目类别:
-
资助金额:$29.35万
-
财政年份:2012
-
负责人:Paul David Benya
-
依托单位:
siRNA Inhibition of Keloid Fibrosis in Fibrin Matrix Skin Equivalent Mouse Models
-
批准号:8256619
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2012
-
负责人:Paul David Benya
-
依托单位:
ECM Remodeling in Excessive Fibroplasia
-
批准号:7751944
-
项目类别:
-
资助金额:$41.05万
-
财政年份:1998
-
负责人:Paul David Benya
-
依托单位:
TGF BETA SIGNALING IN CARTILAGE REPAIR
-
批准号:2082420
-
项目类别:
-
资助金额:$20.1万
-
财政年份:1994
-
负责人:Paul David Benya
-
依托单位:
TGF BETA SIGNALING IN CARTILAGE REPAIR
-
批准号:2082421
-
项目类别:
-
资助金额:$21.54万
-
财政年份:1994
-
负责人:Paul David Benya
-
依托单位:
TGF BETA SIGNALING IN CARTILAGE REPAIR
-
批准号:2082422
-
项目类别:
-
资助金额:$21.95万
-
财政年份:1994
-
负责人:Paul David Benya
-
依托单位:
TGF BETA SIGNALING IN CARTILAGE REPAIR
-
批准号:2442827
-
项目类别:
-
资助金额:$22.56万
-
财政年份:1994
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3154901
-
项目类别:
-
资助金额:$16.36万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3154903
-
项目类别:
-
资助金额:$17.71万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3154900
-
项目类别:
-
资助金额:$16.65万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3151006
-
项目类别:
-
资助金额:$14.24万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3154902
-
项目类别:
-
资助金额:$17.03万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
COLLAGEN IN OSTEOARTHRITIC CARTILAGE
-
批准号:3154897
-
项目类别:
-
资助金额:$16.83万
-
财政年份:1977
-
负责人:Paul David Benya
-
依托单位:
海外基金